Quell Therapeutics

ScaleupBiotech & Life SciencesBritish

Clinical-stage engineered T-regulatory (Treg) cell therapy company targeting conditions driven by aberrant immune responses, including organ transplant rejection, Type 1 Diabetes and inflammatory bowel disease, with a strategic partnership with AstraZeneca.

Locations

London, United Kingdom (Headquarters)

Translation & Innovation Hub, 84 Wood Lane, London, Greater London, W12 0BZ, United Kingdom

View on map